Interaction of cationic antimicrobial peptides with Mycoplasma pulmonis

Ho Jin Park1, Ki Mo Kang, Kevin Dybvig

  • 1Department of Biotechnology, Hoseo University, Asan City, Chungnam 336-795, South Korea.

FEBS Letters
|September 3, 2013
PubMed

Insights

Cationic antimicrobial peptides (AMPs) damage Mycoplasma pulmonis cell membranes, inhibiting growth. Their effectiveness is linked to binding phosphatidylcholine, a key component of the mycoplasma membrane.

Area of Science:

  • Microbiology
  • Biochemistry
  • Cell Biology

Background:

  • Mycoplasma species are significant pathogens causing various infections.
  • Cationic antimicrobial peptides (AMPs) are a crucial part of the innate immune system with broad-spectrum antimicrobial activity.
  • The precise mechanism by which AMPs target and eliminate Mycoplasma remains incompletely understood.

Purpose of the Study:

  • To elucidate the mode of action of cationic antimicrobial peptides (AMPs) against Mycoplasma pulmonis.
  • To investigate the role of membrane integrity and lipid composition in AMP-mediated mycoplasma killing.

Main Methods:

  • Utilized scanning electron microscopy to visualize the effects of AMPs on M. pulmonis.
  • Quantified cell membrane damage by measuring propidium iodide uptake.
  • Assessed the binding affinity of AMPs to phosphatidylcholine.

Main Results:

  • Exposure to AMPs caused significant damage to the M. pulmonis cell membrane within 30 minutes.
  • Propidium iodide uptake confirmed compromised membrane integrity following AMP treatment.
  • The anti-mycoplasma activity correlated with the binding affinity of AMPs to phosphatidylcholine.

Conclusions:

  • Cationic antimicrobial peptides exert their anti-mycoplasma effect by disrupting the cell membrane.
  • Phosphatidylcholine, preferentially located in the outer membrane leaflet, is a key target for AMPs in Mycoplasma.
  • Understanding this mechanism could inform the development of novel anti-mycoplasma therapies.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Surface Membrane Barriers01:18

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Microbial Interactions: Predation01:28

Microbial Interactions: Predation

Microbial predation refers to the process by which one microorganism kills and consumes another to obtain nutrients and energy. It encompasses both bacterial and protozoan predators. This interaction plays a crucial role in shaping microbial communities and regulating nutrient cycling.Bacterial Predators: Epibiotic vs. EndobioticBacterial predators are classified based on their mode of attack as either epibiotic or endobiotic. Epibiotic predators, such as Vampirococcus, attach to the surface of...